EGFR and cancer: c-Met activation is associated with angiogenesis in cancer, involving crosstalk with RTKs such as epidermal growth factor receptor (EGFR), insulin-like growth factor receptor (IGFR), and erb-b2 receptor tyrosine kinase (ERBB2) [206,207].